Fig. 1From: Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment PlansInitial Consensus Treatment Plan (CTP) Choices and Subsequent Treatment Changes. The total numbers of patients started on each CTP are shown, along with those remaining on the original CTP medication (dark blue), switching to a different CTP (green) or adding another CTP medication (light blue). IL1i: IL1 inhibitor; IL6i: IL6 inhibitorBack to article page